Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
High expression level of SOX2 is significantly associated with shorter survival in patients with thymic epithelial tumorsGuk Jin Lee, Heejung Lee, In Sook Woo, et al.European Journal of Gastroenterology & Hepatology|August 6, 2008
High intensity focused ultrasound therapy resulted in a complete response in a patient with advanced gastric cancer with liver metastases: a case reportHye Young Sung, Se Hyun Cho, Jin Il Kim, et al.Cancer Research and Treatment|November 3, 2020
Real-World Clinical Data of Palbociclib in Asian Metastatic Breast Cancer Patients: Experiences from Eight InstitutionsJieun Lee, Hyung Soon Park, Hye Sung Won, et al.Cancer Chemotherapy and Pharmacology|March 26, 2017
Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancerJoungSoon Jang, Hoon-Kyo Kim, Byoung Chul Cho, et al.Asia-Pacific Journal of Clinical Oncology|April 20, 2010
Clinical characteristics and prognostic factors for primary appendiceal carcinomaYoon Ho Ko, Se Hoon Park, Chan-Kwon Jung, et al.Cancer Research and Treatment|September 12, 2009
Clinical characteristics of primary peritoneal carcinomaSang Young Roh, Sook Hee Hong, Yoon Ho Ko, et al.Cancer Chemotherapy and Pharmacology|September 25, 2008
A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancerJae Jin Lee, Si-Young Kim, Hyun-Cheol Chung, et al.Journal of Cancer|October 31, 2022
Real-world experience of safety and effectiveness of regorafenib for treatment of metastatic colorectal cancer, advanced gastrointestinal stromal tumors, and hepatocellular carcinoma: a post-marketing surveillance study in KoreaSeung-Hoon Beom, Ki Beom Bae, Dae Young Zang, et al.The Korean Journal of Internal Medicine|November 22, 2005
Irinotecan, continuous 5-fluorouracil, and low dose of leucovorin (modified FOLFIRI) as first line of therapy in recurrent or metastatic colorectal cancerMyung-Ah Lee, Jae-Ho Byun, Byoung-Young Shim, et al.Japanese Journal of Clinical Oncology|February 1, 2005
A phase II study of epirubicin, cisplatin and uracil-tegafur for advanced gastric carcinomaIn Sook Woo, Do Ho Moon, Byoung Young Shim, et al.Pageof 6